TRxADE Health Inc (MEDS) Actualités

Form 8-K - Current report

Form 8-K - Current report

Superlatus Innovates $151 Billion US Snacking Market with Pulse-Based Protein Twists Under the Brave Robot Brand

TAMPA, FL, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Superlatus Inc. ('Superlatus' or the 'Company') recently merged...

Superlatus, Newly Merged with TRxADE HEALTH, Agrees to Acquire The Urgent Company, Inc. and its portfolio of Consumer Brands from Perfect Day, Inc.

Combined company, focused on sustainable, equitable food portfolio, expected to more readily penetrate new...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

TRxADE HEALTH, Inc. Announces Extension of Form 10-Q Filing

TAMPA, FL, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical...

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form PRE 14A - Other preliminary proxy statements

Newly merged Entity Superlatus, Inc with Trxade Health, Inc. Appoints Leading CPG Management Team

Forbes Fisher Appointed as Chief Operating Officer.Dr. Eugenio Bortone Appointed as Chief Innovation & Food...

Form 8-K - Current report

TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.

NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical...

Form 425 - Prospectuses and communications, business combinations

Form 8-K - Current report

TRxADE HEALTH, Inc. Amends Definitive Merger Agreement with Superlatus, Inc.

NEW YORK, July 14, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical...

Form 8-K - Current report